<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:23:32Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11219" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11219</identifier><datestamp>2026-09-24T21:52:15Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Trigatti, Bernardo L.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Igdoura, Suleiman A.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Truant, Ray</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Wang, David Yu Chang</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:53:58Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:53:58Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-09-19</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2011-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6203</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7209</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2245848</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11219</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/23451</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>In atherosclerotic plaques, macrophages ingest modified LDL and turn to foam cells. Others have shown that SR-BI expression levels inversely correlated with cellular cholesterol levels, and is independent of well characterized cholesterol sensing pathways; SREBP and LXR. Thus the mechanism of regulation of SR-BI is unclear. In this study, we showed that treating macrophage with agents known to increase cellular cholesterol levels, namely acLDL, LDL, MβCD:Cholesterol, resulted in reduction in HMGCoAR mRNA and SR-BI expression levels. In contrast, acLDL did not reduce SR-BI mRNA levels in macrophages from acLDL SR-A KO mice, demonstrating that acLDL mediate suppression of SR-BI was dependent on SR-A. Fucoidan, a known competitive inhibitor of acLDL binding to SR-A, and subsequent degradation, also suppressed SR-BI expression levels. Unlike acLDL, however, fucoidan induced mRNA levels corresponding to the pro-inflammatory genes iNOS and IL-6 mRNA levels, and its effects were not altered by the lack of SR-A. Instead, fucoidan mediated stimulation of iNOS and IL-6 and suppression of SR-BI mRNA levels was prevented by an anti-CD14 blocking antibody, demonstrating that the fucoidan mediated effects were dependent on CD14. Interleukin-15, a pro-inflammatory cytokine that binds to a distinct receptor, also induced iNOS and IL-6 mRNA levels and reduced SR-BI expression, suggesting that inflammatory signaling in general can reduce SR-BI expression levels. Treatment of macrophages with the lipoproteins acLDL, LDL or HDL suppressed the induction of iNOS and IL-6 mRNA by fucoidan or IL-15. Macrophages foam cells in an atherosclerotic plaque may have reduced SR-BI due to exposure with modified LDL or inflammatory cytokines or both in an atherosclerotic plaque. SR-BI expression in macrophages protects against atherosclerosis development. Our data suggests that modified lipoproteins as well as inflammatory stimuli suppress SR-BI expression in macrophages and this may contribute to their pro-apoptotic properties.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Atherosclerosis receptor cholesterol inflammation macrophage lipoprotein</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cell Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Immunity</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Biochemistry</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Cell Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Molecular Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Molecular Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemistry</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Regulation of macrophage SR-BI by lipoproteins and inflammatory stimuli</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>